1146 related articles for article (PubMed ID: 16410796)
1. TLR signaling.
Kawai T; Akira S
Cell Death Differ; 2006 May; 13(5):816-25. PubMed ID: 16410796
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses.
Meylan E; Tschopp J
Mol Cell; 2006 Jun; 22(5):561-9. PubMed ID: 16762830
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors and adaptor molecules in liver disease: update.
Seki E; Brenner DA
Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor and RIG-I-like receptor signaling.
Kawai T; Akira S
Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
[TBL] [Abstract][Full Text] [Related]
5. Innate immune responses: crosstalk of signaling and regulation of gene transcription.
Zhong B; Tien P; Shu HB
Virology; 2006 Aug; 352(1):14-21. PubMed ID: 16753195
[TBL] [Abstract][Full Text] [Related]
6. Unique O-methoxyethyl ribose-DNA chimeric oligonucleotide induces an atypical melanoma differentiation-associated gene 5-dependent induction of type I interferon response.
Burel SA; Machemer T; Ragone FL; Kato H; Cauntay P; Greenlee S; Salim A; Gaarde WA; Hung G; Peralta R; Freier SM; Henry SP
J Pharmacol Exp Ther; 2012 Jul; 342(1):150-62. PubMed ID: 22505629
[TBL] [Abstract][Full Text] [Related]
7. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
8. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
10. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
11. Antiviral innate immunity pathways.
Seth RB; Sun L; Chen ZJ
Cell Res; 2006 Feb; 16(2):141-7. PubMed ID: 16474426
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
13. Signaling to NF-kappaB by Toll-like receptors.
Kawai T; Akira S
Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
[TBL] [Abstract][Full Text] [Related]
14. Suppression of TRIF-dependent signaling pathway of toll-like receptors by allyl isothiocyanate in RAW 264.7 macrophages.
Kim SJ; Park HJ; Shin HJ; Shon DH; Kim DH; Youn HS
Int Immunopharmacol; 2012 Aug; 13(4):403-7. PubMed ID: 22668719
[TBL] [Abstract][Full Text] [Related]
15. TLR signaling.
Akira S
Curr Top Microbiol Immunol; 2006; 311():1-16. PubMed ID: 17048703
[TBL] [Abstract][Full Text] [Related]
16. Toll-IL-1-receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity.
Matsumoto M; Funami K; Oshiumi H; Seya T
Prog Mol Biol Transl Sci; 2013; 117():487-510. PubMed ID: 23663980
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
18. Concomitant TLR/RLH signaling of radioresistant and radiosensitive cells is essential for protection against vesicular stomatitis virus infection.
Spanier J; Lienenklaus S; Paijo J; Kessler A; Borst K; Heindorf S; Baker DP; Kröger A; Weiss S; Detje CN; Staeheli P; Kalinke U
J Immunol; 2014 Sep; 193(6):3045-54. PubMed ID: 25127863
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of Toll-like-receptor signaling by IRF-4.
Negishi H; Ohba Y; Yanai H; Takaoka A; Honma K; Yui K; Matsuyama T; Taniguchi T; Honda K
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15989-94. PubMed ID: 16236719
[TBL] [Abstract][Full Text] [Related]
20. Innate and intrinsic antiviral immunity in skin.
Kawamura T; Ogawa Y; Aoki R; Shimada S
J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
